GFAP and Astrogliosis

Brain Pathology

Volumn 4, Issue 3, 1994, Pages 229-237

  Eng, Lawrence F ^a,b   Ghirnikar, Roopa S ^b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL CELL; ASTROCYTE; BRAIN DISEASE; BRAIN INJURY; CELL CULTURE; CONFERENCE PAPER; GLIOSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN;

ANIMALS; ASTROCYTES; BIOLOGICAL MARKERS; BRAIN; BRAIN DISEASES; BRAIN NEOPLASMS; CELLS, CULTURED; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; SPECIES SPECIFICITY;

EID: 0027931125     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1994.tb00838.x     Document Type: Conference Paper

References (113)

1. A study of proteins in old multiple sclerosis plaques
2. An acidic protein isolated from fibrous astrocytes
3. Turnover of glial fibrillary acidic protein in the mouse
4. Turnover of glial filaments in mouse spinal cord
5. Metabolic studies in vitro of the CNS cytoskeletal proteins: Synthesis and degradation
6. Editorial
7. Intermediate filaments in astrocytes
8. All classes of intermediate filaments share a common antigenic determinant defined by a monoclonal antibody
9. Glial fibrillary acidic protein (GFAP): The major protein of glial intermediate filaments in differentiated astrocytes
10. Immunohistochemistry of nervous system‐specific antigens
11. A reply to the comments of Bignami and Dahl. Isolation of GFA protein from normal brain ‐ A comment
12. The glial fibrillary acidic (GFA) protein
13. Isolation of GFA protein from normal brain‐a comment
14. Immunochemistry of the glial fibrillary acidic protein
15. The glial fibrillary acidic protein and astrocytic 10 nanometer filaments
16. Immunological markers in astrocytes
17. Glial fibrillary acidic protein: A review of structure, function, and clinical application
18. Immunohistochemistry: techniques and application to neurooncology
19. Glial fibrillary acidic protein in cryogenic lesions of the rat brain
20. Immunocytochemical staining for glial fibrillary acidic protein and the metabolism of cytoskeletal proteins in experimental allergic encephalomyelitis
21. Dissociation of GFAP intermediate filaments in EAE: observations in the lumbar spinal cord
22. Cell‐free synthesis of glial fibrillary acidic protein
23. Molecular profile of reactive astrocytes; implications for their role in neurologic diseases
24. The proliferative response of astrocytes to injury in neonatal rat brain. A combined immunocytochemical and autoradiographic study
25. Fibrillary astrocytes proliferate in response to brain injury, a study combining immunoperoxidase technique for glial fibrillary acidic protein and radioautography of tritiated thymidine
26. Observations on the astrocyte response to a cerebral stab wound in adult rats
27. Quantitative studies on proliferative changes of reactive astrocytes in mouse cerebral cortex
28. Possible association of platelet‐derived growth factor (PDGF) with the appearance of reactive astrocytes following brain injury in situ
29. Immunohistochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeletal proteins following brain injury in rats
30. Biochemical and immunocytochemical changes in glial fibrillary acidic protein after stab wounds
31. Increase in glial fibrillary acidic protein following neural trauma
32. Glial fibrillary acidic protein increases in the spinal cord of Lewis rats with acute experimental autoimmune encephalitis
33. Astrocytic reactivity and intermediate filament metabolism in experimental autoimmune encephalomyelitis: the effect of suppression with prazosin
34. Glial fibrillary acidic protein in acute and chronic relapsing experimental allergic encephalomyelitis (EAE)
35. An increase in glial fibrillary acidic protein follows brain hyperthermia in rats
36. Acute systemic heat stress increases glial fibrillary acidic protein immunoreactivity in brain: Experimental observations in conscious normotensive young rats
37. Neuronal activity up‐regulates astroglial gene expression
38. Astroglial response in the excitotoxically lesioned neostriatum and its projection areas in the rat
39. Developmental effects of trimethyltin intoxication in the neonatal mouse. I. Light microscopic studies
40. Acute trimethyltin intoxication in the monkey (Macaca fascicularis)
41. Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity
42. Astrogliosis in the cerebral cortex of gerbils after long‐term exposure to 1,1,1‐trichloroethane
43. Irreversible effects of xylene on the brain after long term exposure: a quantitative study of DNA and the glial cell marker proteins S‐100 and GFA
44. Irreversible effects of dichloromethane on the brain after long term exposure: a quantitative study of DNA and the glial cell maker proteins S‐100 and GFA
45. Stimulation of astrocytes affects cytotoxic brain edema
46. Glial changes following an excitotoxic lesion in the CNS – II. Astrocytes
47. Modulation of GFAP mRNA levels following toxic lesions in the basal ganglia of the rat
48. The neurotoxicant MPTP (1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: Evidence for glial response to injury
49. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
50. 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced astrogliosis does not require activation of ornithine decarboxylase
51. Transient cortical astrogliosis induced by alcohol exposure during the neonatal brain growth spurt in rats
52. Administration of 3,3′‐iminodipropionitrile to the rat results in region‐dependent damage to the central nervous system at levels above the brain stem
53. Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker
54. Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity
55. The molecular pathogenesis of astrogliosis in scrapie and Alzheimer's disease
56. Cloning of a gene whose expression is increased in scrapie and in senile plaques in human brain
57. Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type
58. Astrocyte gene expression in Creutzfeldt‐Jakob disease
59. Glial fibrillary acidic protein messenger RNA and glutamine synthetase activity after nervous system injury
60. GFAP mRNA levels following stab wounds in rat brain
61. Effect of a discrete dorsal forebrain lesion in the rat on the expression of neuronal and glial‐specific genes: Induction of calmodulin, NF‐L, SCI, and GFAP mRNA
62. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning
63. Changes in glial fibrillary acidic protein mRNA expression after corticospinal axotomy in the adult hamster
64. Expression of glial fibrillary acidic protein and neurofilament mRNA in gliosis induced by experimental autoimmune encephalomyelitis
65. The process of reinnervation in the dentate gyrus of adult rats: Time course of increases in mRNA for glial fibrillary acidic protein
66. Expression of mRNA for glial fibrillary acidic protein after experimental cerebral injury
67. GFAP mRNA increases with age in rat and human brain
68. Multiple Sclerosis
69. Adrenoleukodystrophy. A clinical and pathological study of 17 cases
70. Isolation and characterization of glial filaments from human brain
71. Glial fibrillary acidic protein and Alzheimer‐type senile dementia
72. Fibrous astrocytes in senile dementia of the Alzheimer type
73. Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type. An immunohistochemical and ultrastructural study
74. Lamina‐specific arrangement of astrocytic gliosis and senile plaques in Alzheimer disease visual cortex
75. Patterns of gliosis in Alzheimer's disease and aging cerebrum
76. Cerebral amyloid angiopathy and astrocytic gliosis in Alzheimer's disease
77. Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation
78. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease
79. A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition
80. Modified immunocytochemical studies in cerebellar plaques in Alzheimer's disease
81. Neuropathology of organic brain syndromes associated with aging
82. The development of pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome
83. The pathological association between Down's syndrome and Alzheimer's disease
84. Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease
85. Alzheimer's disease: β‐amyloid precursor protein expression in plaques varies among cytoarchitectonic areas of the medial temporal lobe
86. Astrocytic gliosis in the amygdala in Down's syndrome and Alzheimer's disease
87. Immunocytochemical distribution of S‐100 protein in patients with Down's syndrome
88. Brain interleukin 1 and S‐100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
89. Neuronal and glial gene expression in neocortex of Down's syndrome and Alzheimer's disease
90. Thalamic and subcortical gliosis with dementia
91. Huntington's disease: Changes in striatal proteins reflect astrocytic gliosis
92. Quantitative study of gliosis in schizophrenia and Huntington's chorea
93. Gliosis in schizophrenia: A survey
94. Neuropathology of schizophrenia
95. Study of glial fibrillary acidic protein in a human glioma cell line grown in culture and as a solid tumor
96. Degradation of glial fibrillary acidic protein by a calcium dependent proteinase: an electroblot study
97. Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain
98. Hyperproduction de proteine glio‐fibrillaire acide (GFA) au cours de Involution de la tremblante experimental de la soruis
99. Immunohistochemical demonstration of glial fibrillary acidic protein in scrapie
100. The ataxic form of Creutzfeldt‐Jakob disease
101. Reactive astroglia‐neuron relationships in the human cerebellar cortex: A quantitative, morphological and immunocytochemical study in Creutzfeldt‐Jakob disease
102. Glial firillary acidic protein in hepatic encephalopathy. An immunohistochemical study
103. Measurement of GFAP in hepatic encephalopathy by ELISA and transblots
104. The role of astrocytes in hepatic encephalopathy
105. Glial fibrillary acidic protein immunohistochemical study of Alzheimer I & II astrogliosis in Wilson's disease
106. Inhibition of GFAP synthesis by antisense RNA in astrocytes
107. Astrogliosis in culture. I. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis
108. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons
109. Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: Analysis of expression, proliferation, and tumorigenicity
110. Rapid activation of astrocyte‐specific expression of GFA‐LacZ transgene by focal injury